No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Biotech
Overcoming the ‘perfect storm’ in regenerative medicine
Biotech
Autophagy-inducing drug bags funding boost from The Michael J Fox Foundation
Biotech
Tapping the potential of mRNA in cellular reprogramming and beyond
Eterna Therapeutics CEO on harnessing the potential of mRNA engineering in cellular reprogramming, gene therapy and longevity.
Biotech
Connecting the dots of longevity
Biotech
Does SIRT6 hold the key to human longevity?
Biotech
Therini Bio advances its first clinical candidate to treat Alzheimer’s
Biotech
Getting comfortable with senotherapeutics
Biotech
AI identifies three new antiaging senolytic candidates
Biotech
Researchers engineer solution to extend cellular lifespan and slow aging
Biotech
Rubedo announces first-in-class drug candidate for dermatology
Biotech
New Alzheimer’s drug slows cognitive decline by a third
Biotech
Flexible e-tattoo can spot early heart disease red flags
Biotech
Pan-Biome reports positive results in gut microbiome modulator trial
Biotech
Life Biosciences presents data demonstrating restoration of visual function in nonhuman primates
Biotech
UNITY Biotech announces positive results from Phase 2 BEHOLD study on diabetic macular edema
Biotech
Longevity: ‘money-spinning cult’ or the future of health?
Biotech
Longevity investment: ‘Good companies will continue to get funded’
Biotech
Mitochondrial therapy could tackle aging from the inside out
Biotech
Shining a light on cardiovascular aging
Biotech
More power to you – why energy could be the key to longevity
Biotech
Rubedo presents in vivo efficacy data targeting senescent cells
Biotech
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
Biotech
Retro: A longevity biotech triple-threat?
Biotech
Cyclarity: When bad guy cells have a change of heart
Biotech
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Biotech
Cambrian Bio reveals new pipeline company with focus on AMPK activation
Biotech
First longevity clinical study design fetches FDA approval
Biotech
Plant-derived osteoarthritis drug ready for further Phase 2 trials
Biotech
Longevity company Biophysical Therapeutics emerges from stealth
Biotech
Electrodes grown in the brain pave the way for future therapies for neurological disorders
Biotech
Leonhardt Ventures and Lionheart Health file patent for bioelectric control of antiaging protein expression
Biotech
Designing a molecule for longevity
Biotech
Load More